Description

Propofol-Novo Suspension for Infusions 10 mg/ml – 20 ml – N5

Propofol-Novo suspension for infusions contains propofol as the active ingredient.

The recommended dosage of Propofol-Novo suspension for infusions is determined by the healthcare provider based on the patient’s individual needs.

Propofol-Novo suspension for infusions is indicated for the induction and maintenance of anesthesia.

Do not use Propofol-Novo suspension for infusions if the patient has a known hypersensitivity to propofol or any of the ingredients in the formulation.

Propofol-Novo suspension for infusions should be administered by healthcare professionals trained in the administration of general anesthesia.

Propofol acts as a potent agonist at the gamma-aminobutyric acid (GABA) receptor, leading to hyperpolarization of neuronal membranes and inhibition of neurotransmission, resulting in sedative and anesthetic effects.
Research studies have shown that propofol provides rapid onset and offset of anesthesia, making it a preferred choice for many surgical procedures.
Propofol has antiemetic properties, reducing the incidence of postoperative nausea and vomiting.

Propofol-Novo suspension for infusions is formulated to provide a stable and reliable option for anesthesia induction and maintenance.
Clinical trials have demonstrated the effectiveness of propofol in various surgical settings, showing superior outcomes in terms of recovery time and patient satisfaction compared to other anesthetic agents.
The rapid metabolism of propofol contributes to its favorable profile in clinical practice.